Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Inti Bangun Sejahtera Tbk. (IBST) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance

Inti Bangun Sejahtera Tbk.Trade
Hetzer Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Inti Bangun Sejahtera Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? Inti Bangun Sejahtera Tbk. trades at Rp8,475 (market cap 11.45T), while Hetzer Medical Indonesia Tbk. trades at Rp86 (market cap 139.06B, 51.66M 24h volume). The key difference: Inti Bangun Sejahtera Tbk. is far larger — about 82.3× Hetzer Medical Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

IBSTMEDS
Market Cap
11.45T139.06B
Volume
51.66M
Lot
516.62K
Turnover
4.44B
Average Price
85.97
Value
4.44B
Indicative Equilibrium Price
86
Indicative Equilibrium Volume
9.62K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IBST
View details
MEDS
View details

About Inti Bangun Sejahtera Tbk.

PT Inti Bangun Sejahtera Tbk formerly PT Inti Build Prosperous Tbk was established based on Notarial Deed No. 7 dated 28 April 2006 of Yulia, S.H., a notary in Jakarta.At first PT Inti Build Prosperous, Tbk provide signal amplification in buildings (in building system solution). Since the year 2009, PT Inti Build Prosperity has been providing telecommunication infrastructure such as telecommunications tower (tower providers) to meet the needs of mobile telecom operators in Indonesia. And at this time (July 2012) PT Inti Build Prosperity has 1.989 telecommunications tower.Currently, PT Inti Build Prosperous, Tbk provides services for several telecom operators, such as Smart Telecom, Indosat, Telkomsel, XL Axiata, Telkom Flexi, NTS, HCPT, Bakrie Telecom, through leasing tower spread throughout Indonesia.

Read more on IBST

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS